10 Firms Mirror Dow Jones Decline on Monday

7. Geron Corp. (NASDAQ:GERN)

Shares of Geron Corp. decreased by 3.92 percent on Monday to finish the day at $3.43 apiece as investors remained on the sidelines for further developments from the company.

Earlier, the company reported net loss in the third quarter and the first nine months of the year. Albeit a lower net loss in the third quarter, its first nine months registered a higher loss of $149.2 million as compared with the $132.2 million registered year-on-year.

Investors are also waiting on the sidelines for any updates on its drug Rytelo, which aims to treat specific types of myelodysplastic syndromes. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) already recommended the drug for approval to the European Commission, which will review the recommendation. A final decision on market authorization is expected in the coming months.